USANA HEALTH SCIENCES INC (USNA) Fundamental Analysis & Valuation

NYSE:USNA • US90328M1071

Current stock price

16.91 USD
-0.23 (-1.34%)
At close:
16.91 USD
0 (0%)
After Hours:

This USNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. USNA Profitability Analysis

1.1 Basic Checks

  • In the past year USNA was profitable.
  • In the past year USNA had a positive cash flow from operations.
  • USNA had positive earnings in each of the past 5 years.
  • USNA had a positive operating cash flow in 4 of the past 5 years.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • USNA's Return On Assets of 2.34% is in line compared to the rest of the industry. USNA outperforms 59.46% of its industry peers.
  • USNA has a Return On Equity of 3.22%. This is in the better half of the industry: USNA outperforms 67.57% of its industry peers.
  • USNA has a Return On Invested Capital (5.43%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 11.44%.
  • The last Return On Invested Capital (5.43%) for USNA is well below the 3 year average (9.82%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROIC 5.43%
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • USNA's Profit Margin of 1.86% is in line compared to the rest of the industry. USNA outperforms 59.46% of its industry peers.
  • USNA's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 4.58%, USNA perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
  • In the last couple of years the Operating Margin of USNA has declined.
  • USNA has a Gross Margin of 79.18%. This is amongst the best in the industry. USNA outperforms 94.59% of its industry peers.
  • In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
Industry RankSector Rank
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. USNA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), USNA is creating some value.
  • The number of shares outstanding for USNA has been reduced compared to 1 year ago.
  • Compared to 5 years ago, USNA has less shares outstanding
  • USNA has a better debt/assets ratio than last year.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.52 indicates that USNA is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.52, USNA is doing good in the industry, outperforming 75.68% of the companies in the same industry.
  • USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.52
ROIC/WACC0.62
WACC8.71%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 2.23 indicates that USNA has no problem at all paying its short term obligations.
  • USNA has a Current ratio (2.23) which is comparable to the rest of the industry.
  • USNA has a Quick Ratio of 1.46. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.46, USNA is doing good in the industry, outperforming 62.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.46
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. USNA Growth Analysis

3.1 Past

  • USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.15%.
  • The earnings per share for USNA have been decreasing by -20.00% on average. This is quite bad
  • Looking at the last year, USNA shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
  • The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%

3.2 Future

  • Based on estimates for the next years, USNA will show a very strong growth in Earnings Per Share. The EPS will grow by 21.31% on average per year.
  • USNA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.02% yearly.
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. USNA Valuation Analysis

4.1 Price/Earnings Ratio

  • USNA is valuated reasonably with a Price/Earnings ratio of 8.81.
  • Compared to the rest of the industry, the Price/Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 81.08% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. USNA is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 8.29, the valuation of USNA can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, USNA is valued cheaper than 83.78% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, USNA is valued rather cheaply.
Industry RankSector Rank
PE 8.81
Fwd PE 8.29
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaply inside the industry as 97.30% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.56
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • USNA's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)N/A
EPS Next 2Y21.31%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USNA Dividend Analysis

5.1 Amount

  • No dividends for USNA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

USNA Fundamentals: All Metrics, Ratios and Statistics

USANA HEALTH SCIENCES INC

NYSE:USNA (3/20/2026, 8:26:43 PM)

After market: 16.91 0 (0%)

16.91

-0.23 (-1.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-17
Earnings (Next)04-20
Inst Owners58.34%
Inst Owner Change0.34%
Ins Owners0.65%
Ins Owner Change0.54%
Market Cap309.11M
Revenue(TTM)925.26M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (135.25%)
Short Float %3.88%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)2.56%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)4.38%
Valuation
Industry RankSector Rank
PE 8.81
Fwd PE 8.29
P/S 0.34
P/FCF N/A
P/OCF 9.81
P/B 0.59
P/tB 1.26
EV/EBITDA 2.56
EPS(TTM)1.92
EY11.35%
EPS(NY)2.04
Fwd EY12.06%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY10.2%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)1.41
PEG (5Y)N/A
Graham Number35.33
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROCE 6.88%
ROIC 5.43%
ROICexc 7.14%
ROICexgc 18.34%
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
FCFM N/A
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
ROICexc(3y)20.39%
ROICexc(5y)37.76%
ROICexgc(3y)38.56%
ROICexgc(5y)58.83%
ROCE(3y)12.43%
ROCE(5y)20.38%
ROICexgc growth 3Y-33.6%
ROICexgc growth 5Y-29.38%
ROICexc growth 3Y-44.57%
ROICexc growth 5Y-36.69%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 973.94%
Cap/Sales 23.69%
Interest Coverage 62.89
Cash Conversion 49.24%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.46
Altman-Z 3.52
F-Score7
WACC8.71%
ROIC/WACC0.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-22.1%
EBIT growth 5Y-22.03%
EBIT Next Year32.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-381.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.2%
OCF growth 3YN/A
OCF growth 5YN/A

USANA HEALTH SCIENCES INC / USNA Fundamental Analysis FAQ

What is the fundamental rating for USNA stock?

ChartMill assigns a fundamental rating of 5 / 10 to USNA.


Can you provide the valuation status for USANA HEALTH SCIENCES INC?

ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.


Can you provide the profitability details for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 5 / 10.


What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?

The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 8 / 10.


Can you provide the expected EPS growth for USNA stock?

The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 6.25% in the next year.